Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment
Jingbo Qin
1, 2, 3, 4, 5, 6
,
Ningqiang Gong
7
,
Zhihuan Liao
1, 2, 3, 4, 5, 6
,
Shouwen Zhang
6, 8, 9, 10, 11
,
Petr S. Timashev
12, 13, 14, 15, 16, 17
,
Shuaidong Huo
1, 2, 3, 4, 5, 6
,
Jinchao Zhang
1, 2, 3, 4, 5, 6, 7, 18
2
Fujian Provincial Key Laboratory of Innovative Drug Target Research
3
School of Pharmaceutical Sciences
5
Xiamen 361102
6
CHINA
|
8
Neurophysiology Department, Beijing ChaoYang Emergency Medical Center, Beijing 100122, China
|
9
Neurophysiology Department
10
Beijing ChaoYang Emergency Medical Center
|
11
Beijing 100122
|
13
Laboratory of Clinical Smart Nanotechnologies
14
Institute for Regenerative Medicine
16
Moscow 119991
17
Russia
|
Publication type: Journal Article
Publication date: 2021-04-03
scimago Q1
wos Q1
SJR: 1.245
CiteScore: 9.9
Impact factor: 5.1
ISSN: 20403364, 20403372
PubMed ID:
33889907
General Materials Science
Abstract
Mitochondria play critical roles in the regulation of the proliferation and apoptosis of cancerous cells. Nanosystems for targeted delivery of cargos to mitochondria for cancer treatment have attracted increasing attention in the past few years. This review will summarize the state of the art of design and construction of nanosystems used for mitochondria-targeted delivery. The use of nanotechnology for cancer treatment through various pathways such as energy metabolism interference, reactive oxygen species (ROS) regulation, mitochondrial protein targeting, mitochondrial DNA (mtDNA) interference, mitophagy inducing, and combination therapy will be discussed. Finally, the major challenges and an outlook in this field will also be provided.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
|
|
|
Advanced healthcare materials
4 publications, 5.19%
|
|
|
Frontiers in Bioengineering and Biotechnology
3 publications, 3.9%
|
|
|
Small
3 publications, 3.9%
|
|
|
Journal of Controlled Release
3 publications, 3.9%
|
|
|
Coordination Chemistry Reviews
2 publications, 2.6%
|
|
|
Advanced Science
2 publications, 2.6%
|
|
|
Nanoscale
2 publications, 2.6%
|
|
|
MedComm
2 publications, 2.6%
|
|
|
ACS Nano
2 publications, 2.6%
|
|
|
Bioconjugate Chemistry
1 publication, 1.3%
|
|
|
Beilstein Journal of Organic Chemistry
1 publication, 1.3%
|
|
|
DNA and Cell Biology
1 publication, 1.3%
|
|
|
RSC Advances
1 publication, 1.3%
|
|
|
Pharmaceuticals
1 publication, 1.3%
|
|
|
Pharmaceutics
1 publication, 1.3%
|
|
|
Communications Materials
1 publication, 1.3%
|
|
|
Biomaterials Research
1 publication, 1.3%
|
|
|
Signal Transduction and Targeted Therapy
1 publication, 1.3%
|
|
|
Journal of Drug Delivery Science and Technology
1 publication, 1.3%
|
|
|
Materials and Design
1 publication, 1.3%
|
|
|
Molecular Therapy - Nucleic Acids
1 publication, 1.3%
|
|
|
Materials Today Bio
1 publication, 1.3%
|
|
|
Biomaterials
1 publication, 1.3%
|
|
|
Advanced Drug Delivery Reviews
1 publication, 1.3%
|
|
|
Materials Today
1 publication, 1.3%
|
|
|
Cancer Science
1 publication, 1.3%
|
|
|
ChemMedChem
1 publication, 1.3%
|
|
|
ChemNanoMat
1 publication, 1.3%
|
|
|
Advanced Materials
1 publication, 1.3%
|
|
|
1
2
3
4
|
Publishers
|
5
10
15
20
|
|
|
Elsevier
20 publications, 25.97%
|
|
|
Wiley
16 publications, 20.78%
|
|
|
Springer Nature
10 publications, 12.99%
|
|
|
American Chemical Society (ACS)
9 publications, 11.69%
|
|
|
Royal Society of Chemistry (RSC)
9 publications, 11.69%
|
|
|
Frontiers Media S.A.
5 publications, 6.49%
|
|
|
MDPI
3 publications, 3.9%
|
|
|
Beilstein-Institut
1 publication, 1.3%
|
|
|
Mary Ann Liebert
1 publication, 1.3%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.3%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 1.3%
|
|
|
5
10
15
20
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
78
Total citations:
78
Citations from 2024:
34
(44%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Qin J. et al. Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment // Nanoscale. 2021. Vol. 13. No. 15. pp. 7108-7118.
GOST all authors (up to 50)
Copy
Qin J., Gong N., Liao Z., Zhang S., Timashev P. S., Huo S., Zhang J. Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment // Nanoscale. 2021. Vol. 13. No. 15. pp. 7108-7118.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1039/d1nr01068a
UR - https://xlink.rsc.org/?DOI=D1NR01068A
TI - Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment
T2 - Nanoscale
AU - Qin, Jingbo
AU - Gong, Ningqiang
AU - Liao, Zhihuan
AU - Zhang, Shouwen
AU - Timashev, Petr S.
AU - Huo, Shuaidong
AU - Zhang, Jinchao
PY - 2021
DA - 2021/04/03
PB - Royal Society of Chemistry (RSC)
SP - 7108-7118
IS - 15
VL - 13
PMID - 33889907
SN - 2040-3364
SN - 2040-3372
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Qin,
author = {Jingbo Qin and Ningqiang Gong and Zhihuan Liao and Shouwen Zhang and Petr S. Timashev and Shuaidong Huo and Jinchao Zhang},
title = {Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment},
journal = {Nanoscale},
year = {2021},
volume = {13},
publisher = {Royal Society of Chemistry (RSC)},
month = {apr},
url = {https://xlink.rsc.org/?DOI=D1NR01068A},
number = {15},
pages = {7108--7118},
doi = {10.1039/d1nr01068a}
}
Cite this
MLA
Copy
Qin, Jingbo, et al. “Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment.” Nanoscale, vol. 13, no. 15, Apr. 2021, pp. 7108-7118. https://xlink.rsc.org/?DOI=D1NR01068A.